Español
Русский
Português
简体中文
Français
Deutsch
日本語
Italiano
Featured Study Treatment Tools & Device Studies 2011
Safety and Effectiveness of an Internal Pelvic Myofascial Trigger Point Wand for Urological Chronic Pelvic Pain Syndrome (UCPPS)
SUMMARY
This landmark study presented at the American Urological Association provides compelling evidence that the specially designed trigger point wand offers a safe, effective solution for patients with chronic pelvic pain who haven't found relief through conventional treatments. The research validates what many patients have discovered: self-treatment of pelvic floor trigger points can dramatically reduce pain without drugs or surgery.
The wand itself represents a significant innovation in medical device design. Made from rigid Ultem plastic with a curved shape that serves as an "extended finger," it allows patients to reach and treat painful internal trigger points that would otherwise be inaccessible. The integrated algometer - a pressure sensor visible during use - ensures patients apply therapeutic pressure without risk of injury, addressing safety concerns about self-treatment.
Results from 113 patients who completed the 6-month study were remarkable: 95% reported the wand was very or moderately effective in alleviating their pain. The median pain sensitivity score dropped from 7.5 to 4 on a 10-point scale, with 39% of patients experiencing more than 50% reduction in their pelvic muscle sensitivity. These improvements rank the wand "very high amongst other multi-modal treatments" according to the researchers.
Safety data was equally impressive - no serious adverse events occurred during the entire study. Minor issues were limited to temporary increased sensitivity in 12 patients and minimal, transient bleeding in just 3 patients. The protocol is straightforward: after proper training during a 6-day intensive program, patients use the wand at home 2-3 times per week for 5-10 minute sessions. This empowers patients to manage their condition independently while potentially reducing the need for frequent office visits. The study concludes that with simple education on hygiene and careful application technique, self-treatment with an internal pelvic therapeutic wand represents a viable, safe option for refractory pelvic pain patients.
The wand itself represents a significant innovation in medical device design. Made from rigid Ultem plastic with a curved shape that serves as an "extended finger," it allows patients to reach and treat painful internal trigger points that would otherwise be inaccessible. The integrated algometer - a pressure sensor visible during use - ensures patients apply therapeutic pressure without risk of injury, addressing safety concerns about self-treatment.
Results from 113 patients who completed the 6-month study were remarkable: 95% reported the wand was very or moderately effective in alleviating their pain. The median pain sensitivity score dropped from 7.5 to 4 on a 10-point scale, with 39% of patients experiencing more than 50% reduction in their pelvic muscle sensitivity. These improvements rank the wand "very high amongst other multi-modal treatments" according to the researchers.
Safety data was equally impressive - no serious adverse events occurred during the entire study. Minor issues were limited to temporary increased sensitivity in 12 patients and minimal, transient bleeding in just 3 patients. The protocol is straightforward: after proper training during a 6-day intensive program, patients use the wand at home 2-3 times per week for 5-10 minute sessions. This empowers patients to manage their condition independently while potentially reducing the need for frequent office visits. The study concludes that with simple education on hygiene and careful application technique, self-treatment with an internal pelvic therapeutic wand represents a viable, safe option for refractory pelvic pain patients.